Treating Lung Disease in Florida

Florida is home to many progressive medical companies. One such medical treatment facility, the Lung Institute, is leading the new field of adult stem cell therapies for lung disease.

Adult Stem Cell Treatment

Adult stem cells can be utilized in any organ in the body since stem cells are able to mimic any differentiated cell. Since they are capable of self-renewing indefinitely, they can divide many times and can specialize to promote the healing of organs, such as lungs, while still sustaining the original cell.

While there are many options for the type of stem cell used in the science, the Lung Institute only treats with adult autologous stem cells. This means the stem cells are directly coming from a patient’s own body and are later infused back into the same patient. This decreases the possibility of rejection and eliminates any possible controversy associated with stem cells. Through regenerative medicine, stem cells replicate continuously, the lungs grow stronger, and patients are able to breathe easier and live better.

Stem Cell Therapy for Lung Disease

Lung disease like chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, interstitial lung disease and pulmonary fibrosis can be treated with stem cells. These cells are introduced into the body and find the area of diseased cells and

Venous Stem Cell Treatment – Some patients may undergo a venous stem cell treatment. This purely blood-derived treatment is less invasive. In addition, follow-up treatments may need to be performed more often for optimal results.

If you or a loved one suffers from a lung disease and want to learn more about treatment optionscontact us or call (800) 729-3065..

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.